Achieve Life Sciences Operating Income Growth & History (ACHV)
Achieve Life Sciences's operating income was −$54.9M for fiscal 2025.
View full Achieve Life Sciences company overviewAchieve Life Sciences annual operating income history
2018
2019
2022
2023
2024
2025
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$54.9M | −$15.8M | — |
| 2024 | 2024-12-31 | −$39.1M | −$11.8M | — |
| 2023 | 2023-12-31 | −$27.3M | $13.6M | — |
| 2022 | 2022-12-31 | −$40.8M | — | — |
| 2019 | 2019-12-31 | −$16.5M | −$3.7M | — |
| 2018 | 2018-12-31 | −$12.8M | — | — |
Achieve Life Sciences quarterly operating income
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$18.4M | −$5.8M | — |
| Q1 2026 | 2026-03-31 | −$10.5M | $2.4M | — |
| Q4 2025 | 2025-12-31 | −$14.7M | — | — |
| Q3 2025 | 2025-09-30 | −$14.7M | — | — |
| Q2 2025 | 2025-06-30 | −$12.6M | — | — |
| Q1 2025 | 2025-03-31 | −$12.9M | — | — |
| Q3 2012 | 2012-09-30 | $8.3M | $4.2M | +102.34% |
| Q2 2012 | 2012-06-30 | $5.9M | $951,000 | +19.05% |
| Q1 2012 | 2012-03-31 | −$5.5M | −$278,000 | — |
| Q3 2011 | 2011-09-30 | $4.1M | $11.0M | — |
| Q2 2011 | 2011-06-30 | $5.0M | $7.8M | — |
| Q1 2011 | 2011-03-31 | −$5.2M | — | — |
| Q3 2010 | 2010-09-30 | −$6.9M | — | — |
| Q2 2010 | 2010-06-30 | −$2.9M | — | — |
Achieve Life Sciences operating income trends
Between the periods ended 2018-12-31 and 2025-12-31, Achieve Life Sciences's operating income decreased from −$12.8M to −$54.9M, a change of −$42.1M. The latest reported quarter, Q2 2026, shows −$18.4M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Achieve Life Sciences source filings ↗